All-cause health care charges among managed care patients with constipation and comorbid irritable bowel syndrome

Postgraduate Medicine

Volumn 123, Issue 3, 2011, Pages 122-132

  Mitra, Debanjali ^a   Davis, Keith L ^b   Baran, Robert W ^a  

^a RTI HEALTH SOLUTIONS   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

Burden of illness; Constipation; Irritable bowel syndrome; Managed care

Indexed keywords

ADULT; ARTICLE; COMORBIDITY; CONSTIPATION; CONTROLLED STUDY; COST OF ILLNESS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HOSPITAL CHARGE; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MIGRAINE; OUTCOME ASSESSMENT; PRESCRIPTION; QUALITY CONTROL; RESOURCE MANAGEMENT; RISK FACTOR;

EID: 79958735935     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2011.05.2290     Document Type: Article

References (37)

1. American College of Gastroenterology Chronic Constipation Task Force. An evidence-based approach to the management of chronic constipation in North America. Am J Gastroenterol. 2005;100(suppl 1):S1-S4.
2. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130(5):1480-1491.
3. Higgins PD, Johanson JF. Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol. 2004; 99(4):750-759.
4. Camilleri M, Choi MG. Review article: irritable bowel syndrome. Aliment Pharmacol Ther. 1997;11(1):3-15.
5. Drossman DA, Li Z, Andruzzi E, et al. US householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993;38(9):1569-1580.
6. Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology. 1991;101(4):927-934.
7. American College of Gastroenterology. Irritable bowel syndromein women. American College of Gastroenterology Web site. http://www.acg.gi.org/patients/women/ibs.asp.2011. Accessed March 2, 2011.
8. Johanson JF, Sonnenberg A, Koch TR. Clinical epidemiology of chronic constipation. J Clin Gastroenterol. 1989;11(5):525-536.
9. Locke GR, Yawn BP, Wollan PC, Melton LJ, Lydik E, Talley NJ. Incidence of a clinical diagnosis of the irritable bowel syndrome in a United States population. Aliment Pharmacol Ther. 2004;19(9):1025-1031.
10. Lembo A, Camilleri M. Chronic constipation. N Engl J Med. 2003;349(14):1360-1368.
11. Camilleri M, Heading RC, Thompson WG. Consensus report: clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome. Ailment Pharmacol Ther. 2002;16(8):1407-1430.
12. Singh G, Kahler K, Bharathi V, et al. Adults with chronic constipation have significant health care resource utilization and charges of care.Abstract 701. Am J Gastroenterol. 2004;99:S227.
13. Brook RA, Kleinman NL, Melkonian AK, Baran RW. Cost of illness for constipation: medical, pharmacy, and work absence costs in employees with or without constipation. Abstract 1037. Am J Gastroenterol. 2006;101(suppl 2):S408.
14. Rantis PC Jr, Vernava AM, Daniel GL, Longo WE. Chronic constipation-is the work-up worth the cost? Dis Colon Rectum. 1997;40(3):280-286.
15. Inadomi JM, Fennerty MB, Bjorkman D. Systematic review: the economic impact of irritable bowel syndrome. Aliment Pharmacol Ther. 2003;18(7):671-682.
16. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology. 2002;123(6):2108-2131.
17. American Gastroenterological Association. The burden of gastrointestinal diseases. American Gastroenterological Association Web Site. http://www.lewin.com/content/publications/2695.pdf. Accessed March2, 2011.
18. Hulisz D. The burden of illness of irritable bowel syndrome: current challenges and hope for the future. J Manag Care Pharm. 2004;10(4):299-309.
19. Patel RP, Petittta A, Fogel R, Peterson E, Zarowitz BJ. The economic impact of irritable bowel syndrome in a managed care setting. J Clin Gastroenterol. 2002;35(1):14-20.
20. Hay JW, Hay AR. Infl ammatory bowel disease: cost-of-illness. J Clin Gastroenterol. 1992;14(4):309-317.
21. Diamond S, Bigal ME, Silberstein S, et al. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study. Headache. 2007;47(3):355-363.
22. Pesa J, Lage MJ. The medical costs of migraine and comorbid anxiety and depression. Headache. 2004;44(6):562-570.
23. Hawkins K, Rupnow M, Wang S. Direct cost burden of migraine among members of US employers. Value Health. 2006;9:A85.
24. US Department of Labor, Bureau of Labor Statistics. Consumer price index-all urban consumers (current series). Bureau of Labor Statistics Web site. http://data.bls.gov/PDQ/outside.jsp?survey=cu.March2010.Accessed March 2, 2011.
25. Charlson ME, Pompei P, Ales KL, McKenzie CR. A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40(5):373-383.
26. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical co-morbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-619.
27. Meyer B. Natural and quasi experiments in economics. J Bus Econ Stat. 1995;151-161.
28. Wallace NT, Bloom JR, Hu TW, Libby AM. Medication treatment patterns for adults with schizophrenia in Medicaid managed care in Colorado. Psychiatr Serv. 2005;56(11):1402-1408.
29. Bray JW, Zarkin GA, Davis KL, et al. The effect of screening and brief intervention for risky drinking on health care utilization in managed care organizations. Med Care. 2007;45(2):177-182.
30. McCullagh P, Nelder JA. Generalized Linear Models. 2nd ed. London, England: Chapman and Hall; 1989.
31. Nelder JA, Wedderburn RWM. Generalized linear models. J R Stat Soc Ser A Stat Soc. 1972;135:370-384.
32. Wedderburn RWM. Quasi-likelihood functions, generalized linear models, and the Gauss-Newton method. Biometrika. 1974;61:439-447.
33. Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20:461-494.
34. Manning WG. The logged dependent variable, heteroscedasticity, and the retransformation problem. J Health Econ. 1998;17:283-295.
35. Newcomer R, Clay T, Luxenberg JS, et al. Misclassification and selection bias when identifying Alzheimer's disease solely from Medicare claims records. J Am Geriatr Soc. 1999;47(2):215-219.
36. Losina E, Barrett J, Baron JA, et al. Accuracy of medicare claims datafor rheumatologic diagnoses in total hip replacement recipients. J ClinEpidemiol. 2003;56(6):515-519.
37. Friedman B, La Mare J, Andrews R, et al. Assuming an average cost to charge ratio of 0.5: practical options for estimating cost of hospital inpatient stays. J Health Care Finance. 2002;29(1):1-1